The FDA apparently deems an uncontrolled study acceptable – five months after saying no.
ApexOnco Front Page
Recent articles
Could RO7851624, newly into clinical trials, be RG6735?
ESO-T01 delivers its first four multiple myeloma case reports.
Multispecifics newly into the clinic include Car-Ts from Essen and Unicar.
PD-(L)1 x VEGF bispecifics prove a big draw.
The Tang Capital Partners vehicle has already acquired IGM, Elevation and Kronos.
The company, apparently unbothered by Enhertu, is starting a new HER2 x HER2 phase 3.
ADCs newly into human trials include Lilly's PTK7 and two bispecifics.